4.7 Article

First Description of Azole-Resistant Aspergillus fumigatus Due to TR46/Y121F/T289A Mutation in France

期刊

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 59, 期 7, 页码 4331-4335

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00127-15

关键词

-

资金

  1. Astellas
  2. Pfizer
  3. Merck
  4. Gilead
  5. MSD
  6. Basilea

向作者/读者索取更多资源

Azole resistance in Aspergillus fumigatus is an emerging public health concern. Recently, a novel fungicide-driven mutation in the cyp51A gene and its promoter, TR46/Y121F/T289A, leading to high-level resistance to voriconazole has been identified in The Netherlands, Belgium, Germany, Denmark, Tanzania, and India in both clinical and environmental samples. Here we report the first description of A. fumigatus carrying this mutation in France, in a cystic fibrosis patient, underlining the need for extensive monitoring of Aspergillus resistance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据